Onderneming Apontis Pharma AG Deutsche Boerse AG
Aandelen
APPH
DE000A3CMGM5
Farmaceutische producten
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,73 EUR | -0,80% |
|
+0,94% | +84,19% |
Vakgebied
Aantal werknemers: 177
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Single Pills - Hypertension
69,4
%
| 37 | 65,6 % | 26 | 69,4 % | -29,84% |
Co-Marketing - CO PD (Respiratory Diseases)
21,5
%
| 10 | 17,9 % | 8 | 21,5 % | -20,21% |
Corporate Brands (without Single Pills) - Other
5,6
%
| 2 | 3,8 % | 2 | 5,6 % | -3,07% |
Co-Marketing - Cardiovascular
3,1
%
| - | - | 1 | 3,1 % | - |
Co-Marketing - Diabetes
0,5
%
| 7 | 12,3 % | 0 | 0,5 % | -97,44% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Germany
100,0
%
| 56 | 100,0 % | 37 | 100,0 % | -33,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Director of Finance/CFO | - | 01-01-22 | |
Olaf Randerath
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sven Pauly
IRC | Investor Relations Contact | - | - |
Sanjeev Gotru
PRN | Corporate Officer/Principal | - | - |
Susanne Endreß
LAW | General Counsel | - | - |
Harald Weyand
SAM | Sales & Marketing | - | - |
Matthias Wendl
SAM | Sales & Marketing | - | - |
Thomas Milz
PRN | Corporate Officer/Principal | 60 | 01-01-21 |
Susanne Böhme
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edin Hadzic
BRD | Director/Board Member | 54 | 01-01-21 |
Olaf Elbracht
BRD | Director/Board Member | 59 | 01-01-21 |
Chairman | 51 | 01-01-21 | |
Director/Board Member | 39 | 01-01-21 | |
Director/Board Member | - | 01-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 500 000 | 8 330 000 ( 98,00 %) | 170 000 ( 2,000 %) | 98,00 % |
Bedrijfsgegevens
APONTIS PHARMA AG
Alfred-Nobel-Strasse 10
40789, Monheim am Rhein
+49 2173 8955 4949
https://www.apontis-pharma.de![Adres Apontis Pharma AG(APPH)](https://cdn.zonebourse.com/static/address/122323797.png)
Sector
Verkoop per activiteit
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+63,05% | 856 mld. | |
+38,43% | 631 mld. | |
-4,78% | 359 mld. | |
+17,52% | 325 mld. | |
+8,43% | 297 mld. | |
+13,38% | 244 mld. | |
+5,11% | 234 mld. | |
+16,35% | 226 mld. | |
+14,63% | 177 mld. |
- Beurs
- Aandelen
- Koers APPH
- Koers APPH
- Onderneming Apontis Pharma AG